21 April 2022
On 2 March 2022, Dr Katherine Brimblecombe visited two primary school classes (ages 8-11) as part of their “Science week”. Read her interview to learn more about public engagement with school children in the local Oxford community.
13 April 2022
Researchers from the Oxford Parkinson’s Disease Centre (OPDC) recently hosted Caroline Rassell, Parkinson’s UK Chief Executive; David Dexter, Associate Research Director; Trustee Board members, Gary Shaughnessy (Chair) and Sally Bromley; together with members of the Parkinson’s UK Oxford Branch committee, for a visit to showcase the research being carried out in Oxford.
13 December 2021
OPDC's Associate Professor Laura Parkkinen, and her team has conducted a study published in Brain, funded by the charity Parkinson’s UK and Weston Brain Institute.
26 October 2021
A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.
16 February 2021
A study led by University of Oxford researchers, Dr Brent Ryan and Dr Nora Bengoa-Vergniory has shown that the key protein RE1 Silencing Transcription Factor (REST) regulates the health of those neurons critically affected in Parkinson’s Disease.
Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease
4 February 2021
A study led by the Oxford Parkinson’s Disease Centre’s (OPDC) Dr Nora Bengoa-Vergniory has shown that a novel assay termed the tau-proximity ligation assay is able to recognise Alzheimer’s disease before current detection methods.
16 October 2020
New Future Leaders Fellow Dr Beccano-Kelly will lead research into synaptic health over time in neurodegeneration. Watch our video interview with Dayne to find out more about his career to date, successful application and future plans.
2 October 2020
A new collaborative study from the Oxford Parkinson’s Disease Centre led by Prof Stephanie Cragg and Dr Bradley Roberts has revealed that GABA transporters on astrocytes, the brain's lesser known yet critically important cells, support dopamine release and are sites of early dysfunction in parkinsonism.
28 September 2020
A collaborative study led by the OPDC's Dr Nora Bengoa-Vergniory has shown that compounds known as molecular tweezers could become a promising disease modifying therapy for Parkinson’s.
22 September 2020
The World Parkinson Coalition has brought in eight new Science Ambassadors to increase outreach to researchers ahead of their next major Congress.
25 August 2020
New results from a collaborative Oxford Parkinson’s Disease Centre and Cardiff University study on the cellular origins of Parkinson's could be key to developing new treatments.
14 August 2020
OPDC Career Development Fellow Natalie Connor-Robson was first generation in her family to go to university and is now delighted to be sharing STEM career advice with students taking part in the In2scienceUK programme.
30 July 2020
Researchers from the Oxford Parkinson’s Disease Centre (OPDC) have been paying tribute to Bobbie Coelho, one of the OPDC’s long term fundraisers who has decided to take a step back from active fundraising activities.
28 July 2020
OPDC Researcher Dr Dayne Beccano-Kelly shares his experience of being a black professional in academia & the wider story of race in research.
30 April 2020
Wade-Martins Lab members took part in the 2.6 challenge to raise vital funds for Parkinson's UK. Challenges included running for 2.6 miles, baking 26 cookies, 260 sit ups and 2600 steps.